Evista: An All-In-One Curative Drug

Evista is another kind of treatment that cures and restrains osteoporosis in postmenopausal women. It benefits in many ways which is the main reason of its popularity. This medication decreases the risk of invasive breast cancer in postmenopausal women with osteoporosis and reduces the risk of invasive breast cancer in postmenopausal women at high risk.

Evista drug acts by attaching to estrogen receptors on tissues, since estrogen has a positive effect on bone building. It is a very useful medication for osteoporosis and osteopenia. Studies show that Evista decreases cholesterol. It decreases total cholesterol about 7%. It decreases and LDL (bad) cholesterol till 11%. There are no changes in HDL (good) cholesterol. Also, unlike hormone replacement therapy, this osteoporosis and osteopenia medication does not increase the risk of breast or uterine cancer. In clinical studies, women those who take Evista medication experienced no increased risk of breast cancer or uterine cancer.

One of the reasons of its fame and great demand is; this medication does not cause breast tenderness or vaginal bleeding.  It prevents some cancers and brings good news for women concerned about breast cancer or uterine cancer. The results of a 5 years study showed that Raloxifene is as effective in reducing breast cancer. Also women assigned to the raloxifene group had 36% fewer uterine cancers and 29% fewer blood clots.

If you or your family has a history of breast or uterine cancer, Evista is preferably advised by doctors for Osteoporosis or Osteopenai which produces favorable results with great efficiency and helps in curing quickly without any side effect.